全文获取类型
收费全文 | 1514952篇 |
免费 | 120347篇 |
国内免费 | 3697篇 |
专业分类
耳鼻咽喉 | 19749篇 |
儿科学 | 49251篇 |
妇产科学 | 42805篇 |
基础医学 | 214184篇 |
口腔科学 | 39782篇 |
临床医学 | 136565篇 |
内科学 | 305628篇 |
皮肤病学 | 34982篇 |
神经病学 | 126911篇 |
特种医学 | 57281篇 |
外国民族医学 | 468篇 |
外科学 | 225529篇 |
综合类 | 34501篇 |
现状与发展 | 4篇 |
一般理论 | 649篇 |
预防医学 | 119785篇 |
眼科学 | 34011篇 |
药学 | 105832篇 |
3篇 | |
中国医学 | 3501篇 |
肿瘤学 | 87575篇 |
出版年
2021年 | 12517篇 |
2019年 | 13318篇 |
2018年 | 18467篇 |
2017年 | 14145篇 |
2016年 | 15885篇 |
2015年 | 17990篇 |
2014年 | 25421篇 |
2013年 | 37833篇 |
2012年 | 51744篇 |
2011年 | 54808篇 |
2010年 | 32077篇 |
2009年 | 30857篇 |
2008年 | 50984篇 |
2007年 | 53891篇 |
2006年 | 54455篇 |
2005年 | 53083篇 |
2004年 | 50700篇 |
2003年 | 48476篇 |
2002年 | 46601篇 |
2001年 | 73989篇 |
2000年 | 75275篇 |
1999年 | 62582篇 |
1998年 | 18428篇 |
1997年 | 16612篇 |
1996年 | 16525篇 |
1995年 | 15721篇 |
1994年 | 14170篇 |
1993年 | 13381篇 |
1992年 | 46460篇 |
1991年 | 44036篇 |
1990年 | 42028篇 |
1989年 | 40084篇 |
1988年 | 36648篇 |
1987年 | 35801篇 |
1986年 | 33314篇 |
1985年 | 31845篇 |
1984年 | 24503篇 |
1983年 | 20718篇 |
1982年 | 13173篇 |
1981年 | 11666篇 |
1979年 | 21098篇 |
1978年 | 15067篇 |
1977年 | 12545篇 |
1976年 | 11743篇 |
1975年 | 11965篇 |
1974年 | 14280篇 |
1973年 | 13799篇 |
1972年 | 12818篇 |
1971年 | 11586篇 |
1970年 | 11034篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
73.
Severe persistent asthma can have a substantial impact on a patient's health-related quality of life (HRQL), both as a result of symptoms and from side effects of treatment. The HRQL impact of two doses (400 and 800 microg twice daily) of mometasone furoate dry powder inhaler (MF DPI) was compared with placebo in patients with severe persistent asthma previously maintained on oral steroids as a component of a previously published randomized, 12-week, double-blind, placebo-controlled, multicenter trial. A 9-month open-label extension (OLE), with all patients treated with MF DPI, followed. Patients 12 years of age or older completed a generic HRQL measure, the Medical Outcomes Trust Short Form-36 (SF-36), and an asthma-specific measure, the Marks Asthma Quality of Life Questionnaire (AQLQ-M), at baseline, at endpoint (last evaluable visit) of the double-blind phase (EODBP), and after the first 3 months of the OLE. Of 132 patients enrolled in the study, 128 provided HRQL data at baseline and at EODBP. Mean SF-36 scores at baseline showed significant HRQL impairment compared with U.S. general population norms. With treatment, the reduction in oral corticosteroid (OCS) requirements of the MF-DPI-treated groups was accompanied by significant (p < 0.05) improvement over placebo in the physical domain of HRQL (SF-36 physical component summary score and the physical function subscale) at EODBP. MF-DPI-treated patients also showed significant improvements at EODBP in each of the four subscales of the AQLQ-M (p<0.05). From EODBP to the OLE 3-month endpoint, patients treated with MF DPI twice daily maintained, or improved, SF-36 scores in most domains. Symptomatic improvement and reduction in OCS use with MF DPI were accompanied by significant improvement in HRQL in patients with severe persistent asthma. These improvements were maintained during the 3-month period of the OLE in which HRQL was evaluated. 相似文献
74.
75.
Anne Pavy-Le Traon Richard L Hughson Claire Thalamas Monique Galitsky Nelly Fabre Olivier Rascol Jean-Michel Senard 《Movement disorders》2006,21(12):2122-2126
Patients with multiple system atrophy (MSA) present large changes in blood pressure (BP) due to autonomic disturbances. We analyzed how this change may influence dynamic cerebral autoregulation (DCA). Simultaneous recordings of arterial BP (Finapres) and middle cerebral artery (MCA) blood flow velocity (BFV) (transcranial Doppler) were performed in 10 patients with MSA (61 +/- 12 yr of age) and 12 healthy volunteers (61 +/- 11 yr of age): cerebral BFV response to oscillations in mean BP was studied in the supine position by cross-spectral analysis of mean BP and mean MCA BFV. The DCA was also studied during the decrease in BP the first seconds when standing up from a sitting position by the assessment of the cerebrovascular resistance index (CR; mean BP/mean MCA BFV ratio). The MCA BFV/BP cross-spectral analysis showed a phase for the mid-frequency band (0.07-0.2 Hz) significantly larger in MSA, suggesting more active autoregulation in response to larger changes in BP. Changes in CR reflecting the rate of autoregulation, when standing did not differ between the two groups. These data suggest that dynamic cerebral autoregulation is preserved in MSA. 相似文献
76.
Gazzaruso C. Bruno R. Pujia A. 《世界核心医学期刊文摘》2006,2(8):54-54
背景:针对糖尿病患者Lp(a)水平和冠状动脉疾病(CAD)严重程度之间关系的研究较少并且结论有争议。另外,目前尚无关于apo(a)多态性与上述疾病关系的研究。本研究旨在探讨大样本2型糖尿病患者中冠状动脉粥样硬化的程度与Lp(a)水平及apo(a)多态性的相关性。方法:连续选取227例2型糖 相似文献
77.
Chukwuka C Okafor Hana Haleem-Smith Patrice Laqueriere Paul A Manner Rocky S Tuan 《Journal of orthopaedic research》2006,24(3):461-473
Continual loading and articulation cycles undergone by metallic (e.g., titanium) alloy arthroplasty prostheses lead to liberation of a large number of metallic debris particulates, which have long been implicated as a primary cause of periprosthetic osteolysis and postarthroplasty aseptic implant loosening. Long-term stability of total joint replacement prostheses relies on proper integration between implant biomaterial and osseous tissue, and factors that interfere with this integration are likely to cause osteolysis. Because multipotent mesenchymal stem cells (MSCs) located adjacent to the implant have an osteoprogenitor function and are critical contributors to osseous tissue integrity, when their functions or activities are compromised, osteolysis will most likely occur. To date, it is not certain or sufficiently confirmed whether MSCs endocytose titanium particles, and if so, whether particulate endocytosis has any effect on cellular responses to wear debris. This study seeks to clarify the phenomenon of titanium endocytosis by human MSCs (hMSCs), and investigates the influence of endocytosis on their activities. hMSCs incubated with commercially pure titanium particles exhibited internalized particles, as observed by scanning electron microscopy and confocal laser scanning microscopy, with time-dependent reduction in the number of extracellular particles. Particulate endocytosis was associated with reduced rates of cellular proliferation and cell-substrate adhesion, suppressed osteogenic differentiation, and increased rate of apoptosis. These cellular effects of exposure to titanium particles were reduced when endocytosis was inhibited by treatment with cytochalasin D, and no significant effect was seen when hMSCs were treated only with conditioned medium obtained from particulate-treated cells. These findings strongly suggest that the biological responses of hMSCs to wear debris are triggered primarily by the direct endocytosis of titanium particulates, and not mediated by secreted soluble factors. In this manner, therapeutical approaches that suppress particle endocytosis could reduce the bioreactivity of hMSCs to particulates, and enhance long-term orthopedic implant prognosis by minimizing wear-debris periprosthethic osteolysis. 相似文献
78.
79.
80.